Most importantly, increased Ptx3 secretion may correlate with neurodegenerative disease progression, such as Alzheimer’s disease and Parkinson’s disease [11, 27, 28]. This evidence concerns the gene PTX3 and early-onset autosomal dominant Alzheimer disease.